70.0, 68.8, 68.6, 68.2, 57.7, 42.1. IR (CHCl3) n 3369, 2358, 2252,
1757, 1238 cm-1. C34H32FeN2O4 (588.17): calcd. C, 69.39; H, 5.48;
found C, 69.55; H, 5.63.
purification (SiO2, Hex/EtOAc 1:1), 1.1 g (92%) of 3b as a dark
◦
1
brown solid. m. p. 160–162 C. H NMR (300 MHz, CDCl3) d
7.36–7.26 (m, 4H), 7.06-6.93 (m, 6H), 6.54 (c, J = 4.9 Hz, 2H),
5.80 (ddt, J = 16.9, 10.7, 6.9 Hz, 2H), 5.18–5.02 (m, 4H), 4.11
(bs, 2H), 4.04–4.02 (m, 2H), 3.86 (bs, 2H), 3.75–3.72 (m, 2H),
3.56–3.47 (m, 4H), 3.32–3.13 (m, 4H), 2.78 (d, J = 4.9 Hz, 6H).
13C NMR (75 MHz, CDCl3) d 171.8, 157.3, 136.8, 129.8, 122.0,
116.0, 115.1, 89.2, 82.2, 69.4, 68.7, 68.3, 67.2, 57.5, 50.1, 25.8. IR
(CHCl3) n 3498, 2400, 2385, 1716, 1512, 1225 cm-1. C36H42FeN4O4
(650.26): calcd. C, 66.46; H, 6.51; found C, 66.63; H, 6.71.
Ferrocene bis-b-lactam 2d. Following method A, from 2.18 g
(6.26 mmol) of imine 1c, 2.14 g (12.52 mmol) of phenoxyacetyl
chloride and 1.92 g (18.78 mmol) of TEA and after purification
by chromatography (SiO2, Hex/EtOAc 2:1), 3.60 g (93%) of
pure cis,cis bis-b-lactams 2d were obtained as an inseparable 1:1
syn/anti diastereomeric mixture as a light brown solid. 1H NMR
(300 MHz, CDCl3) d 7.29–7.23 (m, 8H), 7.01–6.95 (m, 12H), 5.83–
5.74 (m, 4H), 5.34 (d, J = 4.7 Hz, 2H), 5.33 (d, J = 4.7 Hz, 2H),
5.18–5.10 (m, 8H), 4.77 (d, J = 4.7 Hz, 2H), 4.74 (d, J = 4.7 Hz,
2H), 4.22–4.09 (m, 16 H), 3.63 (dt, J = 14.3, 7.2 Hz, 4H), 3.20 (dt,
J = 13.8, 6.8 Hz, 4H), 2.47–2.27 (m, 8H). 13C NMR (125 MHz,
CDCl3) d 165.7, 165.7, 157.0, 134.2, 129.2, 129.1, 121.8, 117.3,
117.3, 115.3, 115.2, 81.5, 81.4, 80.8, 80.8, 69.7, 69.7, 68.6, 68.5,
57.8, 57.3, 39.2, 39.1, 31.8, 31.8. IR (CHCl3) n 2924, 1754, 1641,
1598, 1494, 1235, 1048 cm-1. C36H36FeN2O4 (616.20): calcd. C,
70.13; H, 5.89; found C, 70.35; H, 5.02.
Synthesis of ferrocenic macrocycles
Lactamic ferrocenic macrocycle 4. A solution of 2c (0.11 g,
0.18 mmol) in 20 mL of anhydrous DCM was added over a
2 h period using a syringe pump to a refluxing deoxygenated
solution of Grubbs 2nd Gen. catalyst (10 mol%) in 180 mL of
anhyd. DCM. The reaction was monitored by T.L.C. until total
disappearance of the starting material (48 h), filtered through a
short pad of SiO2 and evaporated. The crude thus obtained was
purified by flash chromatography (SiO2, Hex/EtOAc 1:1) to obtain
40 mg (36%) of isomer syn-E-4, 40 mg (36%) of isomer anti-E-
Ferrocene bis-b-lactams 2e. Following method A, from 1.00 g
(3.16 mmol) of imine 1d, 1.08 g (6.32 mmol) of phenoxyacetyl
chloride and 0.98 g (9.48 mmol) of TEA and after overnight
Et2O trituration, 1.79 g (97%) of an inseparable 1:1 syn/anti
diastereomeric mixture of cis,cis-bis-b-lactams 2e were obtained
as a light brown solid. 1H NMR (500 MHz, CDCl3) d 7.23 (t, J =
7.3 Hz, 8H), 6.97 (t, J = 7.3 Hz, 4H), 6.88 (d, J = 7.8 Hz, 8H),
5.36 (d, J = 4.8 Hz, 2H), 5.34 (d, J = 4.8 Hz, 2H), 4.96–4.95 (m,
4H), 4.60 (dd, J = 17.6, 2.5 Hz, 2H), 4.59 (dd, J = 17.7, 2.9 Hz,
2H), 4.26–4.19 (m, 16H), 3.90 (d, J = 17.6 Hz, 2H), 3.89 (d, J =
17.7 Hz, 2H), 2.41 (d, J = 2.5 Hz, 2H), 2.40 (d, J = 2.9 Hz, 2H).
13C NMR (125 MHz, CDCl3) d 165.2, 165.2, 157.1, 129.4, 129.3,
122.2, 122.2, 115.6, 115.5, 81.6, 81.6, 81.0, 81.0, 73.5, 73.4, 69.9,
69.9, 69.1, 68.9, 68.3, 68.3, 67.7, 67.7, 57.6, 57.6, 29.5, 29.5. IR
(CHCl3) n 3288, 1761, 1590, 1494, 1234, 1047 cm-1. C34H28FeN2O4
(584.14): calcd. C, 69.87; H, 4.83; found C, 69.94; H, 4.97.
◦
1
4 as orange solids. Syn-E-4. m. p. 219–221 C (dec). H NMR
(500 MHz, C6D6) d 6.99 (dd, J = 8.5, 7.4 Hz, 4H), 6.81 (d, J =
8.5 Hz, 4H), 6.75 (t, J = 7.4 Hz, 2H), 5.86 (m, 1H), 5.83 (m, 1H),
4.75 (d, J = 4.5 Hz, 2H), 4.18 (s, 2H), 3.76 (td, J = 2.4, 1.3 Hz,
2H), 3.70 (d, J = 4.5 Hz, 2H), 3.67 (s, 2H), 3.56 (s, 2H), 3.21 (t, J =
12.5 Hz, 2H), 3.06–3.01 (m, 2H), 2.99 (qd, J = 12.5, 3.9 Hz, 2H),
1.85–1.79 (m, 2H). 13C NMR (75 MHz, CDCl3) d 166.6, 157.0,
131.1, 129.1, 121.9, 115.4, 82.0, 80.9, 69.2, 68.9, 68.5, 68.2, 59.4,
43.2, 30.2. IR (KBr) n 2924, 1755, 1599, 1496, 1358, 1237, 1145,
1030, 804, 755 cm-1. C34H32FeN2O4 (588.17): calcd. C, 69.39; H,
5.48; found C, 69.54; H,◦5.63. MS (FAB) m/z 589 [M + H]+ (12).
1
anti-E-4. m.p. 213–215 C (dec). H NMR (500 MHz, C6D6) d
7.04–6.97 (m, 4H), 6.87 (dd, J = 8.7, 0.9 Hz, 4H), 6.76 (t, J =
7.3 Hz, 2H), 5.60 (m, 1H), 5.55 (m, 1H), 4.89 (d, J = 4.7 Hz, 2H),
4.14 (d, J = 4.7 Hz, 2H), 4.13 (s, 2H), 3.80–3.76 (m,4H), 3.55-3.53
(m, 2H), 3.39–3.30 (m, 2H), 3.14 (ddd, J = 13.3, 8.2, 3.7 Hz, 2H),
2.60–2.50 (m, 2H, 2.17–2.07 (m, 2H). 13C NMR (75 MHz, C6D6) d
166.0, 158.2, 131.9, 129.6, 122.3, 116.2, 82.7, 82.5, 69.0, 68.7, 67.7,
67.6, 58.1, 40.5, 25.9. IR (KBr) n 2924, 1753, 1598, 1494, 1415,
1236, 754 cm-1. MS (FAB) m/z 589 [M + H]+ (43). C34H32FeN2O4
(588.17): calcd. C, 69.39; H, 5.48; found C, 69.48; H, 5.54
Compound 3a. 0.50 g (0.85 mmol) of syn-2c were placed in a
sealed tube and treated with 40% aq. MeNH2 (5 mL, 57.00 mmol).
The tube was sealed and the mixture was heated to 70 ◦C for
48 h until total disappearance of the starting material (T.L.C.).
The crude was then extracted with DCM (2 ¥ 5 mL), dried
(anhyd. MgSO4) and evaporated to yield, after chromatography
purification (SiO2, Hex/EtOAc 1:1), 0.48 g (88%) of 3a as a dark
◦
brown solid. m. p. 138–140 C.1H NMR (300 MHz, CDCl3) d
Lactamic ferrocenic macrocycle 5. A solution of 2e (0.10 g,
0.17 mmol) in 36 mL of anhyd. MeCN was treated with 0.68 g
(3.42◦mmol) of Cu(OAc)2 monohydrate. The mixture was heated
7.25–7.19 (m, 4H), 6.92–6.82 (m, 6H), 6.46 (c, J = 4.9 Hz, 2H),
5.75 (ddt, J = 14.1, 10.0, 6.8 Hz, 2H), 5.14–5.01 (m, 4H), 4.94
(bs, 2H), 4.12 (bs, 2H), 3.98–3.80 (m, 8H), 3.23–3.12 (m, 4H),
2.70 (d, J = 4.9 Hz, 6H). 13C NMR (75 MHz, CDCl3) d 170.8,
157.2, 136.6, 129.6, 121.8, 115.9, 114.9, 89.2, 81.8, 69.2, 68.6, 68.1,
66.8, 57.4, 49.9, 25.6. IR (CHCl3) n 3502, 2400, 1714, 1219 cm-1.
C36H42FeN4O4 (650.26): calcd. C, 66.46; H, 6.51; found C, 66.67;
H, 6.73.
R
to 50 C for 16 h. The reaction was filtrated through Celiteꢀ, evap-
orated and purified by flash chromatography (SiO2, DCM/EtOAc
10:1) to obtain 30.00 mg (30%) of 5 as a 1:1 inseparable mixture of
syn/anti diastereomers as a dark red solid. 1H NMR (300 MHz,
CDCl3) d 7.32–7.23 (m, 10H), 7.05–6.97 (m, 6H), 6.91 (d, J =
8.0, Hz, 4H), 5.39 (bs, 2H), 5.32 (d, J = 4.2 Hz, 2H), 5.17 (bs, 2H),
5.02 (bs, 2H), 4.68 (d, J = 18.6 Hz, 2H), 4.64 (d, J = 18.2, Hz, 2H),
4.44–4.34 (m, 6H), 4.19–4.11 (m, 10H), 4.04 (d, J = 18.2 Hz, 2H),
3.98 (d, J = 18.6 Hz, 2H). 13C NMR (75 MHz, CDCl3) d 166.4,
166.0, 157.5, 157.3, 129.6, 129.4, 122.3, 122.2, 115.8, 115.7, 83.2,
83.0, 81.7, 81.5, 72.5, 72.2, 69.4, 69.1, 68.8, 68.7, 62.5, 61.2, 60.3,
32.6, 32.4. IR (KBr) n 2926, 1759, 1596, 1493, 1415, 1234, 1174,
Compound 3b. 1.00 g (1.70 mmol) of anti-2c were placed
in a sealed tube and treated with 40% aq. MeNH2 (10 mL,
115.00 mmol). The tube was sealed and the mixture was heated to
◦
70 C for 24 h until total disappearance of the starting material
(T.L.C.). The crude was then extracted with DCM (2 ¥ 10 mL),
dried over MgSO4 and evaporated to yield, after chromatography
8404 | Dalton Trans., 2009, 8399–8405
This journal is
The Royal Society of Chemistry 2009
©